AudioScholar Endocrinology Weekly

AudioScholar

Endocrinology — a weekly podcast briefing of the most significant peer-reviewed endocrinology literature, synthesized from PubMed and delivered as ~10-minute audio. For practicing physicians. Generated by AudioScholar at audioscholar.cc.

  1. 1d ago

    This Week in Endocrinology — Aug 18, 2026

    Welcome to This Week in Endocrinology. This week we're covering 10 notable papers spanning new frontiers in type 2 diabetes pharmacotherapy, precision genetics and personalised care across the diabetes spectrum, and long-term risk in survivors — from… This week's papers: 1. Once-weekly IcoSema versus once-daily insulin glargine U100 in type 2 diabetes management (COMBINE 4): an open-label, multicentre, treat-to-target, randomised,… — The Lancet Diabetes & Endocrinology 2026 2. Long-term safety of oral orforglipron in Japanese participants with type 2 diabetes (ACHIEVE-J): a multicentre, randomised, open-label, parallel-group phase 3… — The Lancet Diabetes & Endocrinology 2026 3. SGLT-2 inhibitors and risk of 59 long-term health conditions, hospitalisation, and mortality — European Journal of Endocrinology 2026 4. The liver in diabetes: current state and future perspectives — Diabetologia 2026 5. Precision Medicine in patients with rare forms of genetic obesity: Necessity for coordinated and structured care — Journal of Clinical Endocrinology & Metabolism 2026 6. A multi-centre study of belatacept and sirolimus for islet transplantation — Diabetologia 2026 7. Adult Complications of Childhood-Onset Type 1 Diabetes Vary With Age at Diagnosis: A Population-Based Study — Diabetes Care 2026 8. Clinical Utility of a Type 1 Diabetes Genetic Risk Score Measured as Part of MODY Genetic Testing — Diabetes Care 2026 9. Efficacy and Safety of Time-Restricted Eating in Adults With Type 1 Diabetes: A Randomized Controlled Trial — Diabetes Care 2026 10. Second Primary Malignancies Among Pediatric and Young Adult Survivors of Differentiated Thyroid Cancer: Real-World Evidence — Thyroid 2026 Listen at https://audioscholar.cc/episode/c43gszq3n2

  2. Aug 12

    This Week in Endocrinology — Aug 11, 2026

    Welcome to This Week in Endocrinology. This week we're covering 10 notable papers spanning the expanding cardio-kidney-metabolic reach of incretin therapy and weight loss, adrenal and pituitary disease from diagnostic testing to targeted oncology, an… This week's papers: 1. Effect of semaglutide on kidney outcomes in the SELECT, FLOW, and SOUL trials: a prespecified pooled analysis. — The Lancet Diabetes & Endocrinology 2026 2. Early Weight Loss in Impaired Glucose Tolerance Is Associated With Reduced Long-term Mortality and Cardiovascular Risk: The Da Qing Diabetes Prevention Outcome… — Diabetes Care 2026 3. Impact of adrenalectomy on metabolic alterations and quality of life in mild autonomous cortisol secretion: results from the randomized CHIRACIC trial. — European Journal of Endocrinology 2026 4. Efficacy and safety of once-weekly semaglutide 2.4 mg in Chinese adults with overweight or obesity (STEP 12): a randomised, double-blind, placebo-controlled, m… — The Lancet Diabetes & Endocrinology 2026 5. Belzutifan, A Hypoxia-Inducible Factor 2-Alpha Inhibitor, for Patients with Advanced Pheochromocytoma and Paraganglioma. — Journal of Clinical Endocrinology & Metabolism 2026 6. Decision Tree Prediction of Saline Infusion Test Outcomes in Suspected Primary Aldosteronism: A Multicenter CDM Study. — Journal of Clinical Endocrinology & Metabolism 2026 7. Gestational Diabetes Mellitus: Recurrence and Future Type 2 Diabetes Risk Across Racial and Ethnic Groups. — Diabetes Care 2026 8. Management of Cirrhosis in Diabetes: A Pragmatic Approach to the Patient. — Journal of Clinical Endocrinology & Metabolism 2026 9. Cardiovascular morbidity and mortality in acromegaly-associated diabetes: a Swedish Nationwide study. — Journal of Clinical Endocrinology & Metabolism 2026 10. Temple syndrome - an under-recognised multi-system growth disorder: large cohort analysis and proposed scoring system. — Journal of Clinical Endocrinology & Metabolism 2026 Listen at https://audioscholar.cc/episode/upjt6gujuq

  3. Aug 5

    This Week in Endocrinology — Aug 4, 2026

    Welcome to This Week in Endocrinology. This week we're covering ten notable papers spanning pediatric and genetic endocrinology, diabetes care and risk prediction, and novel management strategies in thyroid and adrenal diseases. Let's dive in. We be… This week's papers: 1. Once-weekly somapacitan enhances linear growth in girls with Turner syndrome: a randomized controlled phase 3 study. — The Journal of clinical endocrinology and metabolism 2026 2. Continuous Glucose Monitoring in Type 2 Diabetes and Beyond: A Review. — JAMA internal medicine 2026 3. Pharmacokinetics of inhaled prednisolone for adrenal crisis: an exploratory study. — European journal of endocrinology 2026 4. Safety of glucagon-like peptide-1 receptor agonists in neuroendocrine neoplasms. — European journal of endocrinology 2026 5. Micro-Costing Analysis of Thyroid Radiofrequency Ablation Compared with Hemithyroidectomy in Outpatient and Inpatient Settings. — Thyroid 2026 6. Is MASLD an independent risk factor for micro- and macrovascular complications of diabetes? A critical reappraisal and future directions. — Diabetologia 2026 7. Predicting future risk of type 1 and type 2 diabetes after gestational diabetes mellitus using polygenic scores: a cohort study. — Diabetologia 2026 8. Maternal Third-Trimester TRAb Is Associated with Neonatal Thyroid Dysfunction and 24-Month Offspring Neurodevelopment: A Bidirectional Cohort Study. — Thyroid 2026 9. Prognostic Stratification of Brain Metastases from Nonanaplastic Follicular Cell-Derived Thyroid Carcinoma: Results of an International Multicenter Retrospecti… — Thyroid 2026 10. Melanocortin-4 Receptor Regulation of Endocrine Axes and Clinical Effects of Setmelanotide. — The Journal of clinical endocrinology and metabolism 2026 Listen at https://audioscholar.cc/episode/knpm8jvjvj

  4. Jul 31

    This Week in Endocrinology — Jul 31, 2026

    Welcome to This Week in Endocrinology. This week we are covering ten notable papers spanning novel dual-acting incretin therapies and vascular diagnostics in diabetes, long-term management and complications in type 1 diabetes, and advanced diagnostic… This week's papers: 1. Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomi… — Lancet 2026 2. Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, rand… — Lancet 2026 3. Diagnostic Tools to Establish the Presence of Peripheral Arterial Disease in People With Diabetes (DMPAD): A Multicenter Comparative Diagnostic Accuracy Study. — Diabetes Care 2026 4. KCNJ5-Dependent 68Ga-Pentixafor PET/CT in Primary Aldosteronism Surgery. — The Journal of Clinical Endocrinology and Metabolism 2026 5. Insulin Pump Use and Hospital Outcomes in Adults With Type 1 Diabetes: A 2022 Nationwide Readmissions Database Analysis. — The Journal of Clinical Endocrinology and Metabolism 2026 6. Type 1 diabetes in older populations. — The Lancet Diabetes & Endocrinology 2026 7. Low measured free testosterone is associated with worse sexual function in community-dwelling men. — European Journal of Endocrinology 2026 9. Cardiac autonomic neuropathy predicts renal decline in type 1 diabetes mellitus: a 15 year follow-up study. — Diabetologia 2026 10. Application of Theranostics in Thyroid Cancer Management. — The Journal of Clinical Endocrinology and Metabolism 2026 Listen at https://audioscholar.cc/episode/fy9jf3rkjm

  5. Jul 15

    This Week in Endocrinology — Jul 14, 2026

    Welcome to This Week in Endocrinology. This week we're covering 10 notable papers spanning the safety, cardiovascular effects, and clinical utility of incretin therapies, advanced management strategies in type 1 diabetes, and emerging diagnostic and… This week's papers: 1. Glucagon-Like Peptide-1 Receptor Agonists and Risk for Ischemic Optic Neuropathy : A Target Trial Emulation. — Annals of internal medicine 2026 2. Glucagon-like Peptide-1 Receptor Agonists and Risk for Anterior Ischemic Optic Neuropathy : A Nationwide Cohort Study. — Annals of internal medicine 2026 3. Comparative Effectiveness of Glucagon-like Peptide-1 Receptor Agonists Versus Oral Agents for Insulin Discontinuation in Type 2 Diabetes : A Target Trial Emula… — Annals of internal medicine 2026 4. Testosterone Reference Ranges in Women, Adolescent Girls, and Children: The 2024 PCOS Challenge-CDC Stakeholder Meeting. — The Journal of clinical endocrinology and metabolism 2026 5. Effects of the Omnipod 5 Hybrid Closed-Loop System in People With Type 1 Diabetes With Impaired Awareness of Hypoglycemia. — Diabetes care 2026 6. Premeal insulin administration lowers postprandial blood glucose and increases myocardial microvascular blood flow in people with type 1 diabetes: a randomised… — Diabetologia 2026 7. Imminent fracture risk: contributing mechanisms, risk assessment and implications for treatment. — The Journal of clinical endocrinology and metabolism 2026 8. Medical Treatments for Obesity: What Does the Future Have in Store? — The Journal of clinical endocrinology and metabolism 2026 9. Non-Glucocorticoid Immunosuppressive Therapy in Post-Glucocorticoid Persistent or Recurrent Primary Autoimmune Hypophysitis: A Systematic Review. — Clinical endocrinology 2026 10. Effects of Pharmacological GIP Infusion on Insulin, Glucagon, and Cardiovascular Responses During Hyperglycemia in Type 2 Diabetes. — Diabetes 2026 Listen at https://audioscholar.cc/episode/678p4hubf6

  6. Jul 8

    This Week in Endocrinology — Jul 7, 2026

    Welcome to This Week in Endocrinology. This week we're covering 10 notable papers spanning advances in type 1 diabetes care, evolving diagnostic paradigms in adrenal and pituitary disorders, and the long-term systemic consequences of endocrine diseas… This week's papers: 1. Human versus analogue insulin for children and young adults with type 1 diabetes in low-resource settings (HumAn-1): a multicentre, open-label, randomised cont… — The Lancet Diabetes & Endocrinology 2026 2. Diagnostic work-up in paediatric adrenocortical tumours: an international consensus — European Journal of Endocrinology 2026 3. Long-term Cancer Risk in Acromegaly: A Population-Based Cohort Study with 44 Years of Follow-up — European Journal of Endocrinology 2026 4. Is diagnosis of Cushing's disease moving beyond Bilateral inferior petrosal sinus sampling? — The Journal of Clinical Endocrinology and Metabolism 2026 5. Using machine learning to discriminate non-classical 21-hydroxylase deficiency from polycystic ovary syndrome: an external validation study — European Journal of Endocrinology 2026 6. Pathophysiology-Based Classification of Male Infertility: Evidence from an 800-patient Prospective Cohort — The Journal of Clinical Endocrinology and Metabolism 2026 7. The Extra X Chromosome and Autoimmune Susceptibility in Klinefelter Syndrome — The Journal of Clinical Endocrinology and Metabolism 2026 8. Children's neurodevelopment at school age after hysterosalpingography with iodinated contrast: a cohort study — The Journal of Clinical Endocrinology and Metabolism 2026 9. The Correlation Between Fear and Perceived Frequency of Hypoglycemia and Continuous Glucose Monitoring Metrics in Adults With Type 1 Diabetes Using Diabetes Te… — Diabetes Care 2026 10. Habituation to Elevated Glucose Levels in Type 1 Diabetes: Function and Well-Being in Guideline-Based Versus Typical Glycemic Range — Diabetes Care 2026 Listen at https://audioscholar.cc/episode/4ga6jp2c4t

  7. Jul 1

    This Week in Endocrinology — Jun 30, 2026

    Welcome to This Week in Endocrinology. This week we are covering ten notable papers spanning advancements in diabetes and glycemic management, diagnostic and therapeutic pathways in adrenal and thyroid disorders, and long-term metabolic and pediatric… This week's papers: 1. Weekly and Biweekly Treatment With Bofanglutide Versus Semaglutide in Chinese Patients With Type 2 Diabetes : A Phase 2b Randomized Clinical Trial. — Annals of internal medicine 2026 2. Real-Time Continuous Glucose Monitoring Among People With Type 2 Diabetes and End-Stage Kidney Failure Undergoing Maintenance Hemodialysis: A Randomized Clinic… — Diabetes care 2026 3. Association of the Primary Aldosteronism Severity Classification with Lateralization and Treatment Outcomes. — The Journal of clinical endocrinology and metabolism 2026 4. Intermittent fasting to treat diabetes: time to update clinical practice guidelines. — The lancet. Diabetes & endocrinology 2026 5. Open-Label 9-Year Follow-Up Extension Phase 2 Study of Once-Weekly Somatrogon in Children With Growth Hormone Deficiency. — The Journal of clinical endocrinology and metabolism 2026 6. Sampling variability and concordance between sequential and simultaneous adrenal venous sampling in primary aldosteronism subtype diagnosis. — European journal of endocrinology 2026 7. Improving post-thyroidectomy care using a PTH and calcium-based algorithm. — European journal of endocrinology 2026 8. Approach to Personalizing the Treatment of Osteoporosis. — The Journal of clinical endocrinology and metabolism 2026 9. Mild Thyroid Eye Disease-The Most Common yet the Least Studied Presentation of Thyroid Eye Disease. — Thyroid : official journal of the American Thyroid Association 2026 10. From Premature Adrenarche to Adult Metabolic Risk and Hyperandrogenism: A Systematic Review and Meta-Analysis. — The Journal of clinical endocrinology and metabolism 2026 Listen at https://audioscholar.cc/episode/mkd9r3ja7h

About

Endocrinology — a weekly podcast briefing of the most significant peer-reviewed endocrinology literature, synthesized from PubMed and delivered as ~10-minute audio. For practicing physicians. Generated by AudioScholar at audioscholar.cc.